Elliott et al., "Synthesis of Potential Antiradiation Agents from 3-substituted 2-oxazolidinones derived from Phenol, Benzenethiol, and Related Compounds", J. Med. Chem., vol. 12, No. 2, pp. 253-257, (1969). |
Chapman, J. D., "Measurement of Tumor Hypoxia by Invasive and Non-Invasive Procedures: A Review of Recent Clinical Studies", Radiother. Oncol., 20, pp. 13-19 (1991). |
Martin, G. V. et al., "Enhanced Binding of the Hypoxic Cell Marker [.sup.3 H]Fluoromisonidaozle in Ischemic Myocardium", J. Nucl. Med., vol. 30, No. 2, 194-201 (1989). |
Hoffman, J. M. et al., "Binding of the Hypoxia Tracer [.sup.3 H]Misonidazole in Cerebral Ischemia", Stroke, 18:168-176 (1987). |
Koh, W. J. et al., "Hypoxia Imaging of Tumors Using [F-18] Fluoromisonidazole", J. Nucl. Med., 30,789 (No. 252) (1989). |
Biskupiak, J. E. et al., "Synthesis of an (Iodovinyl)misonidazole Derivative for Hypoxia Imaging", J Med. Chem., 34, pp. 2165-2168 (1991). |
Chapman, J. D., "The Detection and Measurement of Hypoxic Cells in Solid Tumors", Cancer, vol. 54, No. 11, pp. 2441-2449 (1984). |
Kedderis, G. L. et al., "The Metabolic Activation of Nitroheterocyclic Therapeutic Agents", Drug Metabolism Reviews, 19(1), pp. 33-62 (1988). |
Adams, G. E. et al., "Hypoxia-Mediated Nitro-Heterocyclic Drugs in The Radio-and Chemotherapy of Cancer", Biochemical Pharmacology, vol. 35, No. 1, pp. 71-76 (1986). |
Brown, D. M. et al., "Structure-Activity Relationships of 1-Substituted 2-Nitroimidazoles: Effect of Partition Coefficient and Side-chain Hydroxyl Groups on Radiosensitization In Vitro", Radiation Research, 90, pp. 98-108 (1982). |
Adams, G. E., et al., "Structure Activity Relationships in the Development of Hypoxic Cell Radiosensitizers. I. Sensitization Efficiency", Int. J. Radiat. Biol., vol. 35, No. 2, pp. 133-150 (1979). |
Adams, G. E., et al., "Structure Activity Relationships in the Development of Hypoxic Cell Radiosensitizers, III. Effects of Basic Substituents in Nitroimidazole Sidechains", Int. J. Radiat. Biol., vol. 38, No. 6, pp. 613-626 (1980). |
Jerabek, P.A., et al., "Synthesis and Biodistribution of .sup.18 F-Labeled Fluoronitroimidazoles: Potential In Vivo Markers of Hypoxic Tissue", Appl. Radiat. Isot. vol. 37, No. 7, pp. 599-605 (1986). |
Martin, G. V. et al., "Fluoromisonidazole A Metabolic Marker of Myocyte Hypoxia" Circulation Research, 67, pp. 240-244 (1990). |
Shelton, M. E. et al., "In Vivo Delineation of Myocardial Hypoxia During Coronary Occlusion Using Fluorine-18 Fluoromisonidazole and Positron Emission Tomography: A Potential Approach for Identification of Jeopardized Myocardium", J. Am. College Cardiology, vol. 16, No. 2, pp. 477-485 (Aug. 1990). |
Mannan, R. H. et al., "Radioiodinated 1-(5-Iodo-5-deoxy-.beta.-D-arabinofuranosyl)-2-nitroimidazole (Iodazomycin Arabinoside: IAZA); A Novel Marker of Tissue Hypoxia", The Journal of Nuclear Medicine, vol. 32, No. 9, pp. 1764-1770 (1991). |
Parker, D., "Harnessing the Kinetic Stability of Macrocyclic Complexes In Vivo," presented at the 16th Int. Symp. on Macrocyclic Chemistry, Univ. of Sheffield, UK (Sep. 1-6, 1991). |
Yang, L. et al., "Synthesis of Metronidazole Derivative and Its Distribution in Sarcoma 180 Bearing Mice", J. of Medical Colleges of PLA: 2(3) pp. 265-269 (1987). |
Volkert, W. A. et al., ".sup.99m Tc-propylene amine oxime (99mTc-PnAO); a potential brain radiopharmaceutical", Eur. J. Nucl. Med., 9, pp. 511-516 (1984). |
Kung, H. F., et al., "Synthesis and Biodistribution of Neutral Lipid-Soluble Tc-99m Complexes that Cross the Blood-Brain Barrier", The Journal of Nuclear Medicine, 25, pp. 326-332 (1984). |
Lever, S. Z. et al., "Design, Preparation, and Biodistribution of a Technetium-99m Triaminedithiol Complex to Assess Regional Cerebral Blood Flow", J. Nucl. Med., 26, pp. 1287-1294 (1985). |
Jurisson et al., "Synthesis, Characterization, and X-ray Structural Determination of Technetium (V)-Oxo-Tetradentate Amine Oxime Complexes", Inorg. Chem., 25, pp. 543-549 (1986). |
Ding et al., "Review and Prospectives of Brain Radiopharmaceuticals", Nucl. Sci. J., 29(5), pp. 341-348 (1992). |
Fattorusso et al., J. Chem. Soc., Daltons Trans., p. 752 (1970). |
Moody et al., J. Chem. Soc. Perkin Trans. 1, (1), pp. 18-24 (1972). |
Svetkin et al., Zh. Obshch Khim. 41(11), pp. 2553-2555 (1971). |
Hook et al., Anti-Cancer Drug Res., 4(3), pp. 173-190 (1989). |
Curtius, Hechtenberg. J. Pract. Chem., 105, 314, pp. 289-326 (1922). |
Orna et al., "Correlation of Kinetic Parameters of Nitroreductase Enzymes with Redox Properties of Nitroaromatic Compounds", J. Biol. Chem., vol. 264, 21, pp. 12379-12384 (1989). |
Murmann, K., "The Interaction of 2-Methyl-2-amino-3-butanone Oxime with Nickel (II) and Copper (II) Ions", J. Am. Chem. Soc., pp. 4174-4180 (1958). |
Vassian et al., "Aromatization of an Aliphatic Amine Oxime Nickel(II) Complex by Molecular Oxygen", Inorg. Chemistry, vol. 6, No. 11, pp. 2043-2046 (1967). |
Murmann et al., "An Unsymmetrical transDinitrocobalt(III) Complex. A Crystal Structure Determination." Inorg. Chem., vol. 12, No. 11, pp. 2625-2631 (1973). |
Somin et al., "Oximes of .omega.-dimethylaminoalkanols and Their Derivatives", Zh. Organ. Khim. 1(11), 1973-6 (1965) (Russ.) as abstracted in Chemical Abstracts, CA64.9582(f). |